SRPX2 and gastric cancer: Moreover, it was also reported that gastric cancer patients with overexpression of SRPX2 presented a lower OS and worse prognosis in comparison to patients with low SPRX2, and SRPX2 was considered a useful independent predictor of outcomes [15].